Anna Wakeland, Ph.D.
About Anna Wakeland, Ph.D.
Anna Wakeland, Ph.D., is a Technical Business Development Specialist at Sandia National Laboratories with a background in biomedical sciences and extensive experience in research and technical sales.
Title
Anna Wakeland, Ph.D., serves as a Technical Business Development Specialist at Sandia National Laboratories since 2019.
Professional Experience
Anna Wakeland has held multiple key positions throughout her career, beginning as a Student Research Intern at Sandia National Laboratories in the Materials Reliability Department from 2005 to 2010. She then worked as a Research Assistant in the Department of Cell Biology and Physiology at the University of New Mexico from 2009 to 2010. Her career progressed within the University of California, San Diego, where she worked as a Graduate Student Researcher in Biomedical Sciences from 2010 to 2015, Council Representative from 2011 to 2015, and Clinical Research Associate in 2016. Additionally, she served as a Primary Teaching Assistant at the Salk Institute Mobile Science Lab from 2013 to 2014. Before her current role, she worked as Director of Technical Sales at Cell Applications, Inc. (2016-2017) and Technical Business Development Specialist at AIS, LLC (2017-2019).
Education and Expertise
Anna Wakeland holds a Ph.D. in Biomedical Sciences from the University of California, San Diego, which she obtained from 2010 to 2015. She also earned a Bachelor of Science in Biochemistry from The University of New Mexico from 2006 to 2010. Her expertise includes developing protocols for the differentiation of human pluripotent stem cells and analyzing trophoblast lineage specification to study early human placental development. She further expanded her business acumen by participating in the Biotechnology Life Science Business Immersion Program through the BIOCOM Institute and completing a Micro-MBA Certificate Program at the Rady School of Management.
Achievements and Projects
Anna Wakeland has contributed significantly to various research and business development projects. Notably, she developed protocols for the differentiation of human pluripotent stem cells at the University of California, San Diego. She also analyzed trophoblast lineage specification during her research to understand early human placental development. These contributions underscore her dedication to advancing biomedical sciences and technical business development.